Toggle Main Menu Toggle Search

Open Access padlockePrints

Homoplasmy, heteroplasmy, and mitochondrial dystonia

Lookup NU author(s): Professor Bobby McFarlandORCiD, Professor Patrick Chinnery, Dr Andrew Schaefer, Dr Andrew Morris, Sharon Foster, Dr Helen Tuppen, Dr Vankateswara Ramesh, Emeritus Professor Doug Turnbull, Professor Robert Taylor


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


BACKGROUND: In clinical practice, mitochondrial disease is seldom considered until a variable combination of seizures, alteration in tone, muscle weakness, and developmental problems is evident. However, it is not uncommon for one symptom to occur in isolation and dominate the clinical phenotype. We report six patients from two families where dystonia was the principal clinical manifestation. A mitochondrial etiology was considered in each case because of the association of dystonia with other less prominent clinical features such as epilepsy. METHODS: Histochemical and biochemical analyses were undertaken in skeletal muscle biopsies from individuals in both families. Sequencing of skeletal muscle mtDNA was also performed and suspected mutations were quantified by hot last cycle PCR-RFLP or primer extension assay. Functional consequences of one of the mutations were investigated by measurement of steady state levels of mitochondrial tRNA. RESULTS: Two distinct mitochondrial pathologies were identified: a novel, homoplasmic mitochondrial tRNA (MTTC) mutation and the primary, m.11778G>A Leber hereditary optic neuropathy (LHON) mutation. The mild nature of both mutations has permitted very high levels of mutated mtDNA to accumulate. Patients with the mutation in the MTTC gene have no wild type mtDNA detectable and although the LHON mutation is heteroplasmic in the patients we report, it is commonly observed to be homoplasmic. CONCLUSIONS: The mitochondrial etiology identified in these patients emphasizes the pathologic potential of homoplasmic mutations and has important implications for the investigation and genetic counseling of families where dystonia is the principal clinical feature. We advocate that mitochondrial disease should be given serious consideration in patients with familial, progressive dystonia, particularly when additional neurologic features such as epilepsy are present. ©2007AAN Enterprises, Inc.

Publication metadata

Author(s): McFarland R, Chinnery PF, Blakely EL, Schaefer AM, Morris AAM, Foster SM, Tuppen HAL, Ramesh V, Dorman PJ, Turnbull DM, Taylor RW

Publication type: Article

Publication status: Published

Journal: Neurology

Year: 2007

Volume: 69

Issue: 9

Pages: 911-916

ISSN (print): 0028-3878

ISSN (electronic): 1526-632X

Publisher: Lippincott Williams & Wilkins


DOI: 10.1212/01.wnl.0000267843.10977.4a

PubMed id: 17724295


Altmetrics provided by Altmetric


Funder referenceFunder name
074454Wellcome Trust
G108/539Medical Research Council